Oxford researchers have reportedly received promising news about their coronavirus vaccine


The University of Oxford's Jenner Institute made waves last week when U.K. Health Minister Matt Hancock announced a team is starting trials on a potential coronavirus vaccine of which there could be a million doses by September, which is, in vaccine terms, incredibly fast. There's still a long way to go before determining if the vaccine is viable, but The New York Times reports there's promising news that it may be both safe and effective.
Scientists at the National Institute of Health's Rocky Mountain Laboratory in Montana tested the Oxford vaccine on six rhesus macaques monkeys. The monkeys were exposed to heavy quantities of the coronavirus, an amount that had previously sickened other monkeys in the lab, before receiving a single dose of the vaccine. More than four weeks later all six monkeys were healthy, Dr. Vincent Munster, the researcher who conducted the test, told the Times. That doesn't mean it will work the same way in humans, but Munster noted the rhesus macaque is "pretty much the closest thing we have to humans," so the results are at least promising.
One thing that could hold trials back, however, is if other measures to curb the pandemic, such as social distancing, work too well, the Times reports. In order to get a real sense of a vaccine's efficacy, tests need to be conducted in places where the virus is spreading swiftly. Read more at The New York Times.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
May 31 editorial cartoons
Cartoons Saturday's political cartoons include how much to pay for a pardon, medical advice from a brain worm, and a simple solution to the national debt.
-
5 costly cartoons about the national debt
Cartoons Political cartoonists take on the USA's financial hole, rare bipartisan agreement, and Donald Trump and Mike Johnson.
-
Green goddess salad recipe
The Week Recommends Avocado can be the creamy star of the show in this fresh, sharp salad
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments